Skip to main content
Signal8

Fabbio Patrick

SEC insider (Form 3/4/5 filer). CIK 0001658859. Director at BeyondSpring Inc. (BYSI) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Apr 1, 2026. Located in FLORHAM PARK, NJ.

Companies Fabbio Patrick has filed insider reports for

  • BeyondSpring Inc. (BYSI): Director
  • Protara Therapeutics, Inc. (TARA): Officer, Chief Financial Officer
Fabbio Patrick profile photo

Fabbio Patrick

CIK: 0001658859

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)3 (42.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BeyondSpring Inc. logo
BYSI

BeyondSpring Inc.

Director
Protara Therapeutics, Inc. logo
TARA

Protara Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Apr 1, 2026
    Award

    Stock Options (right to buy)

    Direct
    22.2K shares-
  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Jan 26, 2026
    Tax Payment
    Direct
    3.3K shares at avg. $6.67$22K
  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Jan 20, 2026
    Tax Payment
    Direct
    3.1K shares at avg. $5.60$17K
  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Jan 16, 2026
    Award
    Direct
    28K shares-
  • BeyondSpring Inc. logo
    BYSI

    BeyondSpring Inc.

    Apr 21, 2025
    Award

    Stock Options (right to buy)

    Direct
    23.8K shares-
  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Jan 24, 2025
    Award
    Direct
    23.5K shares-
  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Jan 21, 2025
    Tax Payment
    Direct
    3.1K shares at avg. $4.76$15K

1-7 of 7